Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer's disease in the Alzheimer's Disease Sequencing Project: Study design and methodology
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Nicholas R. Ray, Ajneesh Kumar, Andrew Zaman, Pamela del Rosario, Pedro R. Mena, Masood Manoochehri, Colin Stein, Alyssa N. De Vito, Robert A. Sweet, Timothy J. Hohman, Michael L. Cuccaro, Gary W. Beecham, Edward D. Huey, Christiane Reitz |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer’s Disease in the Alzheimer’s Disease Sequencing Project: study design and methodology
by: Ajneesh Kumar, et al.
Published: (2024)
by: Ajneesh Kumar, et al.
Published: (2024)
Genetic correlation analysis identifies genetic loci shared between Alzheimer’s disease and primary psychiatric disorders
by: Ajneesh Kumar, et al.
Published: (2024)
by: Ajneesh Kumar, et al.
Published: (2024)
Genetic covariance analysis identifies TMEM106B, ACE and ERC2 as genetic loci shared between Alzheimer's disease and primary psychiatric disorders
by: Ajneesh Kumar, et al.
Published: (2025)
by: Ajneesh Kumar, et al.
Published: (2025)
Neuropsychiatric Symptom Phenotype Prevalence in Diverse Older Adults with Alzheimer's Disease
by: Alyssa N. De Vito, et al.
Published: (2025)
by: Alyssa N. De Vito, et al.
Published: (2025)
Objective measures of instrumental activities of daily living and neuropsychiatric symptoms in aging and early‐stage Alzheimer's disease
by: Gad A. Marshall, et al.
Published: (2025)
by: Gad A. Marshall, et al.
Published: (2025)
Genetic correlation analysis identifies TMEM106B , ACE , and ERC2 as genetic loci shared between Alzheimer's disease and primary psychiatric disorders
by: Ajneesh Kumar, et al.
Published: (2026)
by: Ajneesh Kumar, et al.
Published: (2026)
ADSP Neuropsychiatric Symptom (NPS) Harmonization Working Group: A Status Update
by: Pamela Del Rosario, et al.
Published: (2025)
by: Pamela Del Rosario, et al.
Published: (2025)
Speech and language features as indicators of neuropsychiatric symptoms in a memory clinic population
by: Zampeta‐Sofia Alexopoulou, et al.
Published: (2025)
by: Zampeta‐Sofia Alexopoulou, et al.
Published: (2025)
Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms
by: Sonja M. Kagerer, et al.
Published: (2024)
by: Sonja M. Kagerer, et al.
Published: (2024)
Neuropsychiatric symptom subtypes associated with Alzheimer's disease and related dementia neuropathologic changes in the National Alzheimer's Coordinating Center neuropathology cohort
by: Brenna Cholerton, et al.
Published: (2025)
by: Brenna Cholerton, et al.
Published: (2025)
BDNF expression mediates verbal learning and memory in women in a cohort enriched with risk for Alzheimer's disease
by: Kyle J. Edmunds, et al.
Published: (2025)
by: Kyle J. Edmunds, et al.
Published: (2025)
Exploring neuropsychiatric and behavioral symptoms, and social cognitive deficits in the differential diagnosis of behavioral variant of frontotemporal dementia and primary psychiatric disorders: A systematic literature review
by: Femke G. van Dijk, et al.
Published: (2026)
by: Femke G. van Dijk, et al.
Published: (2026)
Cardiometabolic multimorbidity and neuropsychiatric disturbances in multiregional older adults
by: Haoran Zhang, et al.
Published: (2024)
by: Haoran Zhang, et al.
Published: (2024)
The evolving genetic etiology of conotruncal anomalies
by: Adalina Sacco, et al.
Published: (2024)
by: Adalina Sacco, et al.
Published: (2024)
Detecting time‐varying genetic effects in Alzheimer's disease using a longitudinal genome‐wide association studies model
by: Xiaowei Zhuang, et al.
Published: (2024)
by: Xiaowei Zhuang, et al.
Published: (2024)
Racial/ethnic differences in neuropsychiatric disturbances associated with incident dementia
by: Elizabeth A. Wise, et al.
Published: (2024)
by: Elizabeth A. Wise, et al.
Published: (2024)
The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndrome
by: Julianne G. Clina, et al.
Published: (2026)
by: Julianne G. Clina, et al.
Published: (2026)
Interchangeability of CSF and PET to identify Alzheimer's disease pathology
by: Samantha C. Burnham, et al.
Published: (2026)
by: Samantha C. Burnham, et al.
Published: (2026)
Multi‐modal machine learning and gut microbiome pathway analysis for Alzheimer's risk prediction
by: Tallat Jabeen, et al.
Published: (2026)
by: Tallat Jabeen, et al.
Published: (2026)
Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting
by: Steffi De Meyer, et al.
Published: (2025)
by: Steffi De Meyer, et al.
Published: (2025)
An online vignette study of diagnostic testing: Racial and ethnic differences in Alzheimer's disease diagnosis confidence and stigma
by: Shana D. Stites, et al.
Published: (2025)
by: Shana D. Stites, et al.
Published: (2025)
Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome
by: Emily K. Schworer, et al.
Published: (2024)
by: Emily K. Schworer, et al.
Published: (2024)
Pregnant women's informational needs prior to decisions about prenatal diagnosis for chromosomal anomalies—A Q methodological study
by: Ellen Ternby, et al.
Published: (2024)
by: Ellen Ternby, et al.
Published: (2024)
Women's attitudes towards disclosure of genetic information in pregnancy with varying levels of penetrance
by: Vitalia Libman, et al.
Published: (2024)
by: Vitalia Libman, et al.
Published: (2024)
Is there an increased risk of genetic abnormalities in fetuses with congenital heart disease in the setting of growth restriction?
by: Kathleen Gianforcaro, et al.
Published: (2024)
by: Kathleen Gianforcaro, et al.
Published: (2024)
Diagnostic Yield of Serial PR Interval Screening for Fetal Heart Block in Anti‐SSA/SSB Pregnancies
by: Alyssa Yeung, et al.
Published: (2026)
by: Alyssa Yeung, et al.
Published: (2026)
Inconsistencies between prenatal diagnostic and genetic testing laboratories on variant validation of rare monogenic diseases
by: Liling Lin, et al.
Published: (2024)
by: Liling Lin, et al.
Published: (2024)
Examining the propensity and nature of criminal risk behaviours in frontotemporal dementia syndromes and Alzheimer's disease
by: Fiona Kumfor, et al.
Published: (2024)
by: Fiona Kumfor, et al.
Published: (2024)
Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
by: Rachel R. Jin, et al.
Published: (2025)
by: Rachel R. Jin, et al.
Published: (2025)
Identifying cognitive test scores associated with early tau burden in Alzheimer's disease
by: Caitlin M. Terao, et al.
Published: (2025)
by: Caitlin M. Terao, et al.
Published: (2025)
Has the introduction of increased genetic prenatal testing affected rates of termination of pregnancy due to fetal abnormality?
by: Line Raaby, et al.
Published: (2024)
by: Line Raaby, et al.
Published: (2024)
Prenatal exome sequencing, a powerful tool for improving the description of prenatal features associated with genetic disorders
by: Christel Thauvin‐Robinet, et al.
Published: (2024)
by: Christel Thauvin‐Robinet, et al.
Published: (2024)
Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
by: María A. Rodríguez‐Santiago, et al.
Published: (2024)
by: María A. Rodríguez‐Santiago, et al.
Published: (2024)
Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
by: Juliana N. Souza‐Talarico, et al.
Published: (2025)
by: Juliana N. Souza‐Talarico, et al.
Published: (2025)
Maternal cell contamination in postnatal umbilical cord blood samples implies a low risk for genetic misdiagnoses
by: Sanne P. Smeekens, et al.
Published: (2024)
by: Sanne P. Smeekens, et al.
Published: (2024)
Influence of cognitive, neuropsychiatric, and diagnostic factors on financial capacity: A longitudinal analysis of the ADNI cohort
by: Milap A. Nowrangi, et al.
Published: (2025)
by: Milap A. Nowrangi, et al.
Published: (2025)
Cognitive dispersion is related to subtle objective daily functioning changes in older adults with and without cognitive impairment
by: Alyssa N. De Vito, et al.
Published: (2024)
by: Alyssa N. De Vito, et al.
Published: (2024)
Association between BrainAGE and Alzheimer's disease biomarkers
by: Yousaf Abughofah, et al.
Published: (2025)
by: Yousaf Abughofah, et al.
Published: (2025)
General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
by: Thomas Claessen, et al.
Published: (2025)
by: Thomas Claessen, et al.
Published: (2025)
Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease
by: Diana Esteller‐Gauxax, et al.
Published: (2026)
by: Diana Esteller‐Gauxax, et al.
Published: (2026)
Similar Items
-
Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer’s Disease in the Alzheimer’s Disease Sequencing Project: study design and methodology
by: Ajneesh Kumar, et al.
Published: (2024) -
Genetic correlation analysis identifies genetic loci shared between Alzheimer’s disease and primary psychiatric disorders
by: Ajneesh Kumar, et al.
Published: (2024) -
Genetic covariance analysis identifies TMEM106B, ACE and ERC2 as genetic loci shared between Alzheimer's disease and primary psychiatric disorders
by: Ajneesh Kumar, et al.
Published: (2025) -
Neuropsychiatric Symptom Phenotype Prevalence in Diverse Older Adults with Alzheimer's Disease
by: Alyssa N. De Vito, et al.
Published: (2025) -
Objective measures of instrumental activities of daily living and neuropsychiatric symptoms in aging and early‐stage Alzheimer's disease
by: Gad A. Marshall, et al.
Published: (2025)